Press releases 2023

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2023-09-13 21:59
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO har genomfört en riktad nyemission av 1 600 000 aktier till en teckningskurs om 275 kronor per aktie och tillförs en bruttolikvid om 440 miljoner kronor
2023-09-13 21:59
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO has carried out a directed share issue of 1,600,000 shares at a subscription price of SEK 275 per share, raising gross proceeds of SEK 440 million
2023-09-13 18:00
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO intends to carry out a directed share issue
2023-09-13 18:00
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO avser att genomföra en riktad nyemission av aktier
2023-07-25 08:00
News
IR
English
Corporate Information
Other Corporate Information
US FDA grants XVIVO approval to include DCD hearts in IDE Clinical Trial
2023-07-25 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Amerikanska FDA ger XVIVO godkännande att inkludera DCD-hjärtan i sin IDE kliniska studie
2023-07-13 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
XVIVO avlämnar delårsrapport januari-juni 2023
2023-07-13 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
XVIVO presents interim report January-June 2023
2023-07-12 19:16
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO has decided to close the PrimECC® study for further patient inclusions – strategic opportunities will be evaluated
2023-07-12 19:16
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO har beslutat att avsluta ytterligare patientinkludering i studien av PrimECC® – strategiska möjligheter skall utvärderas
2023-07-10 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO inleder ett strategiskt samarbete med MTJ Aviation för att stärka sin tjänst för organhämtning i USA
2023-07-10 15:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO enters into a strategic collaboration with MTJ Aviation to strengthen organ procurement services in the US
2023-07-03 08:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2023-07-03 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2023-06-21 18:33
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO conducts a commercial integration of STAR Teams in the US - strengthening the service offering
2023-06-21 18:33
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO stärker tjänsteerbjudandet i USA genom en kommersiell integration av STAR Teams
2023-05-31 11:00
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Issuance
Increased number of shares and votes in XVIVO Perfusion AB (publ)
2023-05-31 11:00
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Issuance
Ökat antal aktier och röster i XVIVO Perfusion AB (publ)
2023-05-23 15:00
News
IR
English
Corporate Information
Other Corporate Information
Patient inclusion completed in European clinical trial with XVIVO’s heart preservation technology
2023-05-23 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Inklusion av patienter avslutad i XVIVOs europeiska kliniska studie för hjärtpreservation
2023-05-15 07:30
News
IR
English
Corporate Information
Other Corporate Information
XVIVO’s IDE application for its innovative heart preservation technology has been approved by the US FDA
2023-05-15 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVOs IDE-ansökan för sin innovativa hjärtpreservationsteknologi har godkänts av amerikanska FDA
2023-05-11 21:55
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion AB (publ) genomför nyemission av aktier genom kvittning av fordringar
2023-05-11 21:55
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion AB (publ) carries out new issue of shares through set off of claims
2023-04-25 16:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2023-04-25 16:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
2023-04-24 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
XVIVO avlämnar delårsrapport januari-mars 2023
2023-04-24 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q1
XVIVO presents interim report January-March 2023
2023-04-17 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2023-04-17 09:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2023-04-03 22:20
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2022
2023-04-03 22:20
News
IR
English
Regulatory
VPML
Report
Annual
Annual Report 2022
2023-03-23 17:40
News
IR
Swedish
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2023-03-23 17:40
News
IR
English
Corporate Information
General meeting
Notice
Notice to attend the Annual General Meeting in XVIVO Perfusion AB (publ)
2023-01-26 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Yearend
Bokslutskommuniké 2022
2023-01-26 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Yearend
Report on Operations 2022
2023-01-16 15:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO presents Report on Operations 2022
2023-01-16 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké 2022
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2023-09-13 21:59
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO har genomfört en riktad nyemission av 1 600 000 aktier till en teckningskurs om 275 kronor per aktie och tillförs en bruttolikvid om 440 miljoner kronor
2023-09-13 21:59
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO has carried out a directed share issue of 1,600,000 shares at a subscription price of SEK 275 per share, raising gross proceeds of SEK 440 million
2023-09-13 18:00
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO intends to carry out a directed share issue
2023-09-13 18:00
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO avser att genomföra en riktad nyemission av aktier
2023-07-13 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
XVIVO avlämnar delårsrapport januari-juni 2023
2023-07-13 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
XVIVO presents interim report January-June 2023
2023-07-12 19:16
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO has decided to close the PrimECC® study for further patient inclusions – strategic opportunities will be evaluated
2023-07-12 19:16
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO har beslutat att avsluta ytterligare patientinkludering i studien av PrimECC® – strategiska möjligheter skall utvärderas
2023-06-21 18:33
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO conducts a commercial integration of STAR Teams in the US - strengthening the service offering
2023-06-21 18:33
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO stärker tjänsteerbjudandet i USA genom en kommersiell integration av STAR Teams
2023-05-31 11:00
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Issuance
Increased number of shares and votes in XVIVO Perfusion AB (publ)
2023-05-31 11:00
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Issuance
Ökat antal aktier och röster i XVIVO Perfusion AB (publ)
2023-05-11 21:55
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion AB (publ) genomför nyemission av aktier genom kvittning av fordringar
2023-05-11 21:55
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion AB (publ) carries out new issue of shares through set off of claims
2023-04-25 16:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2023-04-25 16:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
2023-04-24 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
XVIVO avlämnar delårsrapport januari-mars 2023
2023-04-24 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q1
XVIVO presents interim report January-March 2023
2023-04-03 22:20
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2022
2023-04-03 22:20
News
IR
English
Regulatory
VPML
Report
Annual
Annual Report 2022
Next